Nanobiotix S.A. (NANO.PA)

EUR 3.48

(1.93%)

Total Liabilities Summary of Nanobiotix S.A.

  • Nanobiotix S.A.'s latest annual total liabilities in 2023 was 95.74 Million EUR , up 10.28% from previous year.
  • Nanobiotix S.A.'s latest quarterly total liabilities in 2024 Q2 was 108.45 Million EUR , down 0.0% from previous quarter.
  • Nanobiotix S.A. reported annual total liabilities of 86.81 Million EUR in 2022, up 15.78% from previous year.
  • Nanobiotix S.A. reported annual total liabilities of 74.97 Million EUR in 2021, up 17.96% from previous year.
  • Nanobiotix S.A. reported quarterly total liabilities of 95.74 Million EUR for 2023 FY, up 10.28% from previous quarter.
  • Nanobiotix S.A. reported quarterly total liabilities of 95.74 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Nanobiotix S.A. (2023 - 2011)

Historical Annual Total Liabilities of Nanobiotix S.A. (2023 - 2011)

Year Total Liabilities Total Liabilities Growth
2023 95.74 Million EUR 10.28%
2022 86.81 Million EUR 15.78%
2021 74.97 Million EUR 17.96%
2020 63.56 Million EUR 9.38%
2019 58.11 Million EUR 81.88%
2018 31.95 Million EUR 135.9%
2017 13.54 Million EUR 4.16%
2016 13 Million EUR 20.33%
2015 10.8 Million EUR 60.38%
2014 6.73 Million EUR 58.29%
2013 4.25 Million EUR 27.93%
2012 3.32 Million EUR 67.4%
2011 1.98 Million EUR 0.0%

Peer Total Liabilities Comparison of Nanobiotix S.A.

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -1285.127%
ABIVAX Société Anonyme 131.05 Million EUR 26.945%
Adocia SA 31.87 Million EUR -200.408%
Aelis Farma SA 13.08 Million EUR -631.957%
Biophytis S.A. 15.84 Million EUR -504.076%
Advicenne S.A. 24.37 Million EUR -292.747%
genOway Société anonyme 14.45 Million EUR -562.125%
IntegraGen SA 5.97 Million EUR -1501.058%
Medesis Pharma S.A. 6.42 Million EUR -1389.842%
Neovacs S.A. 3.71 Million EUR -2479.116%
NFL Biosciences SA 3.62 Million EUR -2544.252%
Plant Advanced Technologies SA 6.78 Million EUR -1311.605%
Quantum Genomics Société Anonyme 3.31 Million EUR -2792.354%
Sensorion SA 13.22 Million EUR -623.808%
Theranexus Société Anonyme 5.01 Million EUR -1808.62%
TME Pharma N.V. 2.78 Million EUR -3337.702%
Valbiotis SA 13.7 Million EUR -598.424%
TheraVet SA 1.48 Million EUR -6347.168%
Valerio Therapeutics Société anonyme 20.46 Million EUR -367.755%
argenx SE 402.79 Million EUR 76.231%
BioSenic S.A. 32.26 Million EUR -196.739%
Celyad Oncology SA 9.97 Million EUR -859.511%
DBV Technologies S.A. 38.74 Million USD -147.101%
Galapagos NV 1.56 Billion EUR 93.87%
Genfit S.A. 105.92 Million EUR 9.612%
GeNeuro SA 20.13 Million EUR -375.375%
Hyloris Pharmaceuticals SA 8.61 Million EUR -1011.705%
Innate Pharma S.A. 132.29 Million EUR 27.63%
Inventiva S.A. 101.59 Million EUR 5.761%
MaaT Pharma SA 22.46 Million EUR -326.174%
MedinCell S.A. 77.77 Million EUR -23.107%
Onward Medical N.V. 25.69 Million EUR -272.558%
Oryzon Genomics S.A. 25.12 Million EUR -281.047%
OSE Immunotherapeutics SA 59.07 Million EUR -62.054%
Oxurion NV 19.73 Million EUR -385.103%
Pharming Group N.V. 228.28 Million EUR 58.061%
Poxel S.A. 53.9 Million EUR -77.622%
GenSight Biologics S.A. 34.72 Million EUR -175.693%
Transgene SA 26.51 Million EUR -261.051%
Financière de Tubize SA 123.65 Million EUR 22.572%
UCB SA 6.56 Billion EUR 98.541%
Valneva SE 341.14 Million EUR 71.936%
Vivoryon Therapeutics N.V. 4.54 Million EUR -2005.564%